Here's an equity analyst-style summary for retail investors: **1. Business Performance:** IPL reported strong Q3 FY26: revenue up 31% YoY to ₹229 Cr, PAT jumped 41% to ₹23 Cr.

9M FY26 also saw revenue at ₹808 Cr (+28% YoY) and PAT at ₹89 Cr (+44% YoY). Robust exports and domestic herbicide demand fueled growth. **2. Growth Drivers or Strategy:** Capacity expansion at Sandila & Hamirpur (₹116 Cr FY26 capex) is key.

In-house R&D and backward integration boost product range, cut import reliance, and support a 'China plus one' strategy. **3. Recent Developments:** IPL advanced sustainability with 6 MW solar power at Sandila (Oct 2025). They secured 5 new India & 6 overseas product registrations, plus commissioned an intermediate plant for key fungicide backward integration. **4. Key Financial Metrics:** Q3 FY26 EPS surged 40.7% YoY to ₹1.97, with EBITDA margin expanding to 17.9%. **5. Management Commentary / Outlook:** Management is confident in sustained growth from steady export demand, domestic market recovery, and capacity expansion benefits, focusing on portfolio diversity and operational excellence for long-term value.